Skip to main content
. 2015 Aug 6;6(28):24947–24968. doi: 10.18632/oncotarget.4453

Figure 1. Characterization of anti-EpCAM mAbs (EpAb1-3, EpAb2-6, EpAb3-5, EpAb4-1, and EpAb5-4).

Figure 1

Binding activities of anti-EpCAM mAbs were measured by Western blotting A. and B. immunofluorescent staining C. and flow cytometry D.